Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

55 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Combination ATR and PARP Inhibitor (CAPRI): A phase 2 study of ceralasertib plus olaparib in patients with recurrent, platinum-resistant epithelial ovarian cancer.
Shah PD, Wethington SL, Pagan C, Latif N, Tanyi J, Martin LP, Morgan M, Burger RA, Haggerty A, Zarrin H, Rodriguez D, Domchek S, Drapkin R, Shih IM, Smith SA, Dean E, Gaillard S, Armstrong D, Torigian DA, Hwang WT, Giuntoli R, Simpkins F. Shah PD, et al. Among authors: wethington sl. Gynecol Oncol. 2021 Nov;163(2):246-253. doi: 10.1016/j.ygyno.2021.08.024. Epub 2021 Oct 5. Gynecol Oncol. 2021. PMID: 34620496 Free PMC article. Clinical Trial.
Minimally invasive hysterectomy surgery rates for endometrial cancer performed at National Comprehensive Cancer Network (NCCN) Centers.
Bergstrom J, Aloisi A, Armbruster S, Yen TT, Casarin J, Leitao MM Jr, Tanner EJ, Matsuno R, Machado KK, Dowdy SC, Soliman PT, Wethington SL, Stone RL, Levinson KL, Fader AN. Bergstrom J, et al. Among authors: wethington sl. Gynecol Oncol. 2018 Mar;148(3):480-484. doi: 10.1016/j.ygyno.2018.01.002. Epub 2018 Jan 12. Gynecol Oncol. 2018. PMID: 29338923 Free PMC article.
Adjuvant therapy for early stage, endometrial cancer with lymphovascular space invasion: Is there a role for chemotherapy?
Beavis AL, Yen TT, Stone RL, Wethington SL, Carr C, Son J, Chambers L, Michener CM, Ricci S, Burkett WC, Richardson DL, Staley AS, Ahn S, Gehrig PA, Torres D, Dowdy SC, Sullivan MW, Modesitt SC, Watson C, Veade A, Ehrisman J, Havrilesky L, Secord AA, Loreen A, Griffin K, Jackson A, Viswanathan AN, Jager LR, Fader AN. Beavis AL, et al. Among authors: wethington sl. Gynecol Oncol. 2020 Mar;156(3):568-574. doi: 10.1016/j.ygyno.2019.12.028. Epub 2020 Jan 14. Gynecol Oncol. 2020. PMID: 31948730 Free PMC article.
The addition of metformin to progestin therapy in the fertility-sparing treatment of women with atypical hyperplasia/endometrial intraepithelial neoplasia or endometrial cancer: Little impact on response and low live-birth rates.
Acosta-Torres S, Murdock T, Matsuno R, Beavis AL, Stone RL, Wethington SL, Levinson K, Grumbine F, Ferriss JS, Tanner EJ, Fader AN. Acosta-Torres S, et al. Among authors: wethington sl. Gynecol Oncol. 2020 May;157(2):348-356. doi: 10.1016/j.ygyno.2020.02.008. Epub 2020 Feb 19. Gynecol Oncol. 2020. PMID: 32085863
Patient reported outcomes measures in gynecologic oncology: A primer for clinical use, part I.
Sisodia RC, Dewdney SB, Fader AN, Wethington SL, Melamed A, Von Gruenigen VE, Zivanovic O, Carter J, Cohn DE, Huh W, Wenzel L, Doll K, Cella D, Dowdy SC. Sisodia RC, et al. Among authors: wethington sl. Gynecol Oncol. 2020 Jul;158(1):194-200. doi: 10.1016/j.ygyno.2020.04.696. Gynecol Oncol. 2020. PMID: 32580886 Free PMC article. No abstract available.
55 results